Azacitidine With Carboplatin and Paclitaxel for Newly Diagnosed Ovarian Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00842582
Recruitment Status : Withdrawn (No enrollment. Unable to recruit due to lack of eligible patients.)
First Posted : February 12, 2009
Last Update Posted : November 2, 2016
Celgene Corporation
Information provided by (Responsible Party):
Loyola University

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Actual Primary Completion Date : March 2011
  Actual Study Completion Date : March 2011